> top > docs > PMC:2664230 > spans > 18909-19332 > annotations

PMC:2664230 / 18909-19332 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T8305 396-403 Regulation denotes effects
T8306 407-412 Protein denotes TNF-α
T8307 413-422 Gene_expression denotes synthesis
R6793 T8306 T8307 themeOf TNF-α,synthesis
R6794 T8307 T8305 themeOf synthesis,effects

2_test

Id Subject Object Predicate Lexical cue
18568240-14960994-22101126 251-253 14960994 denotes 19

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T8698 0-2 PRP denotes We
T8699 3-7 VBD denotes used
T8700 8-9 DT denotes a
T8701 10-21 JJ denotes nonspecific
T8702 22-39 NN denotes phosphodiesterase
T8703 40-49 NN denotes inhibitor
T8704 49-50 , denotes ,
T8705 51-54 NNP denotes PTX
T8706 54-55 , denotes ,
T8707 56-58 IN denotes in
T8708 59-62 DT denotes the
T8709 63-70 JJ denotes present
T8710 71-76 NN denotes study
T8711 77-84 IN denotes because
T8712 85-87 PRP denotes it
T8713 88-91 VBZ denotes has
T8714 92-96 VBN denotes been
T8715 97-101 VBN denotes used
T8716 102-112 RB denotes clinically
T8717 113-115 IN denotes in
T8718 116-119 DT denotes the
T8719 120-129 NN denotes treatment
T8720 130-132 IN denotes of
T8721 133-134 DT denotes a
T8722 135-142 NN denotes variety
T8723 143-145 IN denotes of
T8724 146-156 NNS denotes conditions
T8725 157-159 IN denotes in
T8726 160-165 WDT denotes which
T8727 166-178 NN denotes inflammation
T8728 179-181 VBZ denotes is
T8729 182-184 DT denotes an
T8730 185-194 JJ denotes important
T8731 195-204 NN denotes component
T8732 205-207 IN denotes of
T8733 208-211 DT denotes the
T8734 212-227 NN denotes pathophysiology
T8735 228-230 IN denotes of
T8736 231-234 DT denotes the
T8737 235-242 NN denotes disease
T8738 243-250 NN denotes process
T8739 250-253 CD denotes .19
T8740 254-266 RB denotes Additionally
T8741 266-267 , denotes ,
T8742 268-271 DT denotes the
T8743 272-275 NN denotes use
T8744 276-278 IN denotes of
T8745 279-282 NNP denotes PTX
T8746 283-285 IN denotes in
T8747 286-292 NN denotes sepsis
T8748 293-295 IN denotes as
T8749 296-298 DT denotes an
T8750 299-306 NN denotes adjunct
T8751 307-309 TO denotes to
T8752 310-315 JJ denotes other
T8753 316-326 NNS denotes treatments
T8754 327-329 TO denotes to
T8755 330-338 VB denotes maintain
T8756 339-347 JJ denotes adequate
T8757 348-353 NN denotes organ
T8758 354-362 NN denotes function
T8759 363-366 VBZ denotes has
T8760 367-371 VBN denotes been
T8761 372-380 VBN denotes explored
T8762 381-386 VBN denotes based
T8763 387-391 IN denotes upon
T8764 392-395 PRP$ denotes its
T8765 396-403 NNS denotes effects
T8766 404-406 IN denotes on
T8767 407-412 JJ denotes TNF-α
T8768 413-422 NN denotes synthesis
T8769 422-423 . denotes .
R7119 T8698 T8699 nsubj We,used
R7120 T8699 T8699 ROOT used,used
R7121 T8700 T8703 det a,inhibitor
R7122 T8701 T8703 amod nonspecific,inhibitor
R7123 T8702 T8703 compound phosphodiesterase,inhibitor
R7124 T8703 T8699 dobj inhibitor,used
R7125 T8704 T8703 punct ",",inhibitor
R7126 T8705 T8703 appos PTX,inhibitor
R7127 T8706 T8703 punct ",",inhibitor
R7128 T8707 T8699 prep in,used
R7129 T8708 T8710 det the,study
R7130 T8709 T8710 amod present,study
R7131 T8710 T8707 pobj study,in
R7132 T8711 T8715 mark because,used
R7133 T8712 T8715 nsubjpass it,used
R7134 T8713 T8715 aux has,used
R7135 T8714 T8715 auxpass been,used
R7136 T8715 T8699 advcl used,used
R7137 T8716 T8715 advmod clinically,used
R7138 T8717 T8715 prep in,used
R7139 T8718 T8719 det the,treatment
R7140 T8719 T8717 pobj treatment,in
R7141 T8720 T8719 prep of,treatment
R7142 T8721 T8722 det a,variety
R7143 T8722 T8720 pobj variety,of
R7144 T8723 T8722 prep of,variety
R7145 T8724 T8723 pobj conditions,of
R7146 T8725 T8728 prep in,is
R7147 T8726 T8725 pobj which,in
R7148 T8727 T8728 nsubj inflammation,is
R7149 T8728 T8699 conj is,used
R7150 T8729 T8731 det an,component
R7151 T8730 T8731 amod important,component
R7152 T8731 T8728 attr component,is
R7153 T8732 T8731 prep of,component
R7154 T8733 T8734 det the,pathophysiology
R7155 T8734 T8732 pobj pathophysiology,of
R7156 T8735 T8734 prep of,pathophysiology
R7157 T8736 T8738 det the,process
R7158 T8737 T8738 compound disease,process
R7159 T8738 T8735 pobj process,of
R7160 T8739 T8731 appos .19,component
R7161 T8740 T8761 advmod Additionally,explored
R7162 T8741 T8761 punct ",",explored
R7163 T8742 T8743 det the,use
R7164 T8743 T8761 nsubjpass use,explored
R7165 T8744 T8743 prep of,use
R7166 T8745 T8744 pobj PTX,of
R7167 T8746 T8743 prep in,use
R7168 T8747 T8746 pobj sepsis,in
R7169 T8748 T8743 prep as,use
R7170 T8749 T8750 det an,adjunct
R7171 T8750 T8748 pobj adjunct,as
R7172 T8751 T8750 prep to,adjunct
R7173 T8752 T8753 amod other,treatments
R7174 T8753 T8751 pobj treatments,to
R7175 T8754 T8755 aux to,maintain
R7176 T8755 T8750 relcl maintain,adjunct
R7177 T8756 T8758 amod adequate,function
R7178 T8757 T8758 compound organ,function
R7179 T8758 T8755 dobj function,maintain
R7180 T8759 T8761 aux has,explored
R7181 T8760 T8761 auxpass been,explored
R7182 T8761 T8761 ROOT explored,explored
R7183 T8762 T8761 prep based,explored
R7184 T8763 T8762 prep upon,based
R7185 T8764 T8765 poss its,effects
R7186 T8765 T8763 pobj effects,upon
R7187 T8766 T8765 prep on,effects
R7188 T8767 T8768 amod TNF-α,synthesis
R7189 T8768 T8766 pobj synthesis,on
R7190 T8769 T8761 punct .,explored

UBERON-AE

Id Subject Object Predicate Lexical cue
T8274 348-353 http://purl.obolibrary.org/obo/UBERON_0000062 denotes organ

GO-BP

Id Subject Object Predicate Lexical cue
T9866 413-422 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T9872 166-178 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T9891 22-39 http://purl.obolibrary.org/obo/GO_0008081 denotes phosphodiesterase
T9894 22-49 http://purl.obolibrary.org/obo/GO_0051344 denotes phosphodiesterase inhibitor

GO-MF

Id Subject Object Predicate Lexical cue
T10035 22-39 http://purl.obolibrary.org/obo/GO_0008081 denotes phosphodiesterase

sentences

Id Subject Object Predicate Lexical cue
T8382 0-423 Sentence denotes We used a nonspecific phosphodiesterase inhibitor, PTX, in the present study because it has been used clinically in the treatment of a variety of conditions in which inflammation is an important component of the pathophysiology of the disease process.19 Additionally, the use of PTX in sepsis as an adjunct to other treatments to maintain adequate organ function has been explored based upon its effects on TNF-α synthesis.
T138 0-423 Sentence denotes We used a nonspecific phosphodiesterase inhibitor, PTX, in the present study because it has been used clinically in the treatment of a variety of conditions in which inflammation is an important component of the pathophysiology of the disease process.19 Additionally, the use of PTX in sepsis as an adjunct to other treatments to maintain adequate organ function has been explored based upon its effects on TNF-α synthesis.

events-check-again

Id Subject Object Predicate Lexical cue
T10588 396-403 Regulation denotes effects
T10589 407-412 Protein denotes TNF-α
T10590 413-422 Gene_expression denotes synthesis
R8437 T10589 T10590 themeOf TNF-α,synthesis
R8442 T10590 T10588 themeOf synthesis,effects

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T10143 51-54 Protein denotes PTX
T10144 279-282 Protein denotes PTX
T10145 407-412 Protein denotes TNF-α
T10146 413-422 Gene_expression denotes synthesis
T10147 396-403 Regulation denotes effects
R8224 T10145 T10146 themeOf TNF-α,synthesis
R8225 T10146 T10147 themeOf synthesis,effects

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T9723 407-410 P01375 denotes TNF
T9724 407-412 P01375 denotes TNF-α

test2

Id Subject Object Predicate Lexical cue Speculation
T8201 396-403 Regulation denotes effects
T8202 407-412 Protein denotes TNF-α
T8203 413-422 Gene_expression denotes synthesis true
R6729 T8202 T8203 themeOf TNF-α,synthesis
R6730 T8203 T8201 themeOf synthesis,effects